The expression of GSDM protein family in HNSCC and its impact on prognosis

doi:10.12439/kqhm.1005-4979.2025.01.006

Abstract

Abstract:

Objective: To investigate the expression of Gasdermin (GSDM) protein family in squamous cell carcinoma of head and neck (HNSCC) and its diagnostic and prognostic value.Methods: Based on UALCAN and other public databases, the differential expression of GSDM protein family in HNSCC and its correlation with poor prognosis of HNSCC patients were analyzed, and the correlation between GSDM protein family and immune cell infiltration was clarified.Results: Compared with normal tissues, GSDM protein family was significantly increased in HNSCC tissues, and it was closely correlated with longer overall survival (OS) and immune cell infiltration in HNSCC patients. The gene function of GSDM protein family in HNSCC was mainly concentrated in pyrodeath. The Kyoto Encyclopedin of Genes and Genomes (KEGG) pathway was mainly rich in human papilloma virus infection. The GSDM protein family had a certain mutation rate in HNSCC.Conclusion: Based on tumor bioinformatics analysis, the expression level of GSDM protein family in HNSCC tissues is different from that in normal tissues, and its expression level is correlated with immune cell inflitration and tumor prognosis, which can be used as a prognostic marker of HNSCC and a target for gene therapy.

Key words: head and neck squamous cell carcinoma, GSDM protein family, prognosis, immune cell infiltration

摘要：

目的： 探讨细胞焦亡相关蛋白Gasdermin (GSDM)家族在头颈部鳞状细胞癌（squamous cell carcinoma of head and neck，HNSCC）中的表达及临床意义。方法： 基于UALCAN等公共数据库分析GSDM蛋白家族在HNSCC中的差异表达及其与HNSCC患者不良预后的相关性，同时明确GSDM蛋白家族与免疫细胞浸润的相关性。结果：与正常组织相比，GSDM蛋白家族在HNSCC组织中的表达显著增加，且其与HNSCC患者更长的总生存期（overall survival，OS）及免疫细胞浸润密切相关；GSDM蛋白家族在HNSCC中的基因功能主要富集在细胞焦亡等；京都基因和基因组数据库（Kyoto Encyclopedia of Genes and Genomes，KEGG）通路主要富集人乳头状瘤病毒感染等；GSDM蛋白家族在HNSCC中有一定突变率。结论：GSDM蛋白家族在HNSCC组织中的表达水平与正常组织有差异，且其表达水平与免疫细胞浸润及肿瘤预后具有相关性，可作为HNSCC预后标志物及基因治疗靶点。

关键词: 头颈部鳞状细胞癌, GSDM蛋白家族, 预后, 免疫细胞浸润

CLC Number:

R782
R739.8

LIU Wei, SHANG Duo, WU Xu, ZHOU Xing'an, SU Nite, Deleheibateer. The expression of GSDM protein family in HNSCC and its impact on prognosis[J]. 《Journal of Oral and Maxillofacial Surgery》, 2025, 35(1): 34-42.

刘炜, 尚多, 武旭, 周兴安, 苏尼特, 德乐黑巴特尔. GSDM蛋白家族在头颈部鳞状细胞癌中的表达及其对预后的影响[J]. 《口腔颌面外科杂志》, 2025, 35(1): 34-42.

/ / Recommend / Download Citations

URL: https://journal06.magtech.org.cn/Jweb_joms/EN/10.12439/kqhm.1005-4979.2025.01.006

https://journal06.magtech.org.cn/Jweb_joms/EN/Y2025/V35/I1/34

Figures/Tables 8

Figure 1 mRNA expression levels of GSDM protein family in HNSCC and normal tissues of head and neck

Figure 2 mRNA expression of GSDM protein family in HNSCC tissues and normal tissues of head and neck

Figure 3 mRNA expression of GSDM protein family in different pathological stages of HNSCC patients

Figure 4 Prognostic value of GSDM protein family genes in HNSCC patients

Figure 5 Relationship between differentially expressed GSDM protein family mRNA and immune cell infiltration in HNSCC

Figure 6 Functional analysis and protein interaction network analysis of GSDM protein family-related co-expressed genes

Figure 7 Relationship between HNSCC patients and gene mutations of differentially expressed GSDM protein family

Figure 8 Differentially expressed GSDM protein family gene mutation sites in HNSCC patients

References 26

[1]	Tarle M, Lukšić I. Pathogenesis and therapy of oral carcinogenesis[J]. Int J Mol Sci, 2024, 25(12): 6343.
[2]	Bhat GR, Hyole RG, Li J. Head and neck cancer: Current challenges and future perspectives[J]. Adv Cancer Res, 2021, 152: 67-102. doi: 10.1016/bs.acr.2021.05.002 pmid: 34353444
[3]	Du TT, Gao J, Li PL, et al. Pyroptosis, metabolism, and tumor immune microenvironment[J]. Clin Transl Med, 2021, 11(8): e492.
[4]	Tan YX, Chen QZ, Li XL, et al. Pyroptosis: A new paradigm of cell death for fighting against cancer[J]. J Exp Clin Cancer Res, 2021, 40(1): 153. doi: 10.1186/s13046-021-01959-x pmid: 33941231
[5]	Hsu SK, Chen YE, Shu ED, et al. The pyroptotic and nonpyroptotic roles of gasdermins in modulating cancer progression and their perspectives on cancer therapeutics[J]. Arch Immunol Ther Exp, 2023, 71(1): 14.
[6]	Tomczak K, Czerwińska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): An immeasurable source of knowledge[J]. Contemp Oncol, 2015, 19(1A): A68-A77.
[7]	Chandrashekar DS, Karthikeyan SK, Korla PK, et al. UALCAN: An update to the integrated cancer data analysis platform[J]. Neoplasia, 2022, 25: 18-27. doi: 10.1016/j.neo.2022.01.001 pmid: 35078134
[8]	Tang ZF, Li CW, Kang BX, et al. GEPIA a web server for cancer and normal gene expression profiling and interactive analyses[J]. Nucleic Acids Res, 2017, 45(W1): W98-W102.
[9]	Nagy Á, Munkácsy G, Győrffy B. Pancancer survival analysis of cancer hallmark genes[J]. Sci Rep, 2021, 11(1): 6047. doi: 10.1038/s41598-021-84787-5 pmid: 33723286
[10]	Gao JJ, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal[J]. Sci Signal, 2013, 6(269): pl1.
[11]	Li TW, Fan JY, Wang BB, et al. TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells[J]. Cancer Res, 2017, 77(21): e108-e110.
[12]	Szklarczyk D, Kirsch R, Koutrouli M, et al. The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest[J]. Nucleic Acids Res, 2023, 51(D1): D638-D646.
[13]	Shen WT, Song ZG, Zhong X, et al. Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform[J]. Imeta, 2022, 1(3): e36.
[14]	Zou J, Zheng YX, Huang Y, et al. The versatile gasdermin family: Their function and roles in diseases[J]. Front Immunol, 2021, 12: 751533.
[15]	Hu Y, Liu Y, Zong L, et al. The multifaceted roles of GSDME-mediated pyroptosis in cancer: Therapeutic strategies and persisting obstacles[J]. Cell Death Dis, 2023, 14(12): 836. doi: 10.1038/s41419-023-06382-y pmid: 38104141
[16]	Li LS, Li YJ, Bai YX. Role of GSDMB in pyroptosis and cancer[J]. Cancer Manag Res, 2020, 12: 3033-3043. doi: 10.2147/CMAR.S246948 pmid: 32431546
[17]	Shi JJ, Gao WQ, Shao F. Pyroptosis: Gasdermin-mediated programmed necrotic cell death[J]. Trends Biochem Sci, 2017, 42(4): 245-254. doi: S0968-0004(16)30182-7 pmid: 27932073
[18]	Cui YQ, Meng F, Zhan WL, et al. High expression of GSDMC is associated with poor survival in kidney clear cell cancer[J]. Biomed Res Int, 2021, 2021: 5282894.
[19]	Hergueta-Redondo M, Sarrió D, Molina-Crespo Á, et al. Gasdermin-B promotes invasion and metastasis in breast cancer cells[J]. PLoS One, 2014, 9(3): e90099.
[20]	Mu MC, Yu QL, Zhang Q, et al. A pan-cancer analysis of molecular characteristics and oncogenic role of gasdermins[J]. Cancer Cell Int, 2022, 22(1): 80. doi: 10.1186/s12935-022-02483-4 pmid: 35164740
[21]	Kovacs SB, Miao EA. Gasdermins: Effectors of pyroptosis[J]. Trends Cell Biol, 2017, 27(9): 673-684. doi: S0962-8924(17)30084-3 pmid: 28619472
[22]	Feng SY, Fox D, Man SM. Mechanisms of gasdermin family members in inflammasome signaling and cell death[J]. J Mol Biol, 2018, 430(18 Pt B): 3068-3080. doi: S0022-2836(18)30530-8 pmid: 29990470
[23]	Tang R, Xu J, Zhang B, et al. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity[J]. J Hematol Oncol, 2020, 13(1): 110.
[24]	van den Bulk J, Verdegaal EM, de Miranda NF. Cancer immunotherapy: Broadening the scope of targetable tumours[J]. Open Biol, 2018, 8(6): 180037.
[25]	Hassin O, Oren M. Drugging p53 in cancer: One protein, many targets[J]. Nat Rev Drug Discov, 2023, 22(2): 127-144.
[26]	Groelly FJ, Fawkes M, Dagg RA, et al. Targeting DNA damage response pathways in cancer[J]. Nat Rev Cancer, 2023, 23(2): 78-94.

Please choose a citation manager

Content to export